Gujarat Themis Biosyn Statistics

Total Valuation

Gujarat Themis Biosyn has a market cap or net worth of INR 32.05 billion. The enterprise value is 31.90 billion.

Market Cap	32.05B
Enterprise Value	31.90B

Important Dates

The last earnings date was Monday, November 11, 2024.

Earnings Date	Nov 11, 2024
Ex-Dividend Date	Jul 15, 2024

Share Statistics

Gujarat Themis Biosyn has 108.97 million shares outstanding. The number of shares has increased by 0.15% in one year.

Current Share Class	n/a
Shares Outstanding	108.97M
Shares Change (YoY)	+0.15%
Shares Change (QoQ)	-0.15%
Owned by Insiders (%)	2.99%
Owned by Institutions (%)	1.15%
Float	29.19M

Valuation Ratios

The trailing PE ratio is 60.93.

PE Ratio	60.93
Forward PE	n/a
PS Ratio	20.80
PB Ratio	14.34
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 43.55, with an EV/FCF ratio of -1,232.12.

EV / Earnings	60.53
EV / Sales	20.67
EV / EBITDA	43.55
EV / EBIT	46.88
EV / FCF	-1,232.12

Financial Position

The company has a current ratio of 2.53, with a Debt / Equity ratio of 0.02.

Current Ratio	2.53
Quick Ratio	2.26
Debt / Equity	0.02
Debt / EBITDA	0.05
Debt / FCF	-1.31
Interest Coverage	195.83

Financial Efficiency

Return on equity (ROE) is 26.26% and return on invested capital (ROIC) is 20.89%.

Return on Equity (ROE)	26.26%
Return on Assets (ROA)	19.09%
Return on Capital (ROIC)	20.89%
Revenue Per Employee	9.71M
Profits Per Employee	3.31M
Employee Count	159
Asset Turnover	0.69
Inventory Turnover	10.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +138.14% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+138.14%
50-Day Moving Average	331.67
200-Day Moving Average	295.60
Relative Strength Index (RSI)	41.34
Average Volume (20 Days)	86,398

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Gujarat Themis Biosyn had revenue of INR 1.54 billion and earned 527.01 million in profits. Earnings per share was 4.83.

Revenue	1.54B
Gross Profit	948.31M
Operating Income	680.50M
Pretax Income	706.93M
Net Income	527.01M
EBITDA	715.68M
EBIT	680.50M
Earnings Per Share (EPS)	4.83

Full Income Statement

Balance Sheet

The company has 181.09 million in cash and 33.97 million in debt, giving a net cash position of 147.13 million or 1.35 per share.

Cash & Cash Equivalents	181.09M
Total Debt	33.97M
Net Cash	147.13M
Net Cash Per Share	1.35
Equity (Book Value)	2.23B
Book Value Per Share	20.51
Working Capital	315.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 887.78 million and capital expenditures -913.67 million, giving a free cash flow of -25.89 million.

Operating Cash Flow	887.78M
Capital Expenditures	-913.67M
Free Cash Flow	-25.89M
FCF Per Share	-0.24

Full Cash Flow Statement

Margins

Gross margin is 61.45%, with operating and profit margins of 44.09% and 34.15%.

Gross Margin	61.45%
Operating Margin	44.09%
Pretax Margin	45.81%
Profit Margin	34.15%
EBITDA Margin	46.37%
EBIT Margin	44.09%
FCF Margin	-1.68%

Dividends & Yields

This stock pays an annual dividend of 0.67, which amounts to a dividend yield of 0.23%.

Dividend Per Share	0.67
Dividend Yield	0.23%
Dividend Growth (YoY)	-7.41%
Years of Dividend Growth	n/a
Payout Ratio	13.79%
Buyback Yield	-0.15%
Shareholder Yield	0.08%
Earnings Yield	1.64%
FCF Yield	-0.08%

Dividend Details

Stock Splits

The last stock split was on August 9, 2024. It was a forward split with a ratio of 1.5.

Last Split Date	Aug 9, 2024
Split Type	Forward
Split Ratio	1.5

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a